Arbor Rapha Capital Bioholdings I Common Stock

The latest common stock for ARCK is $180M as of September 2022. That compares with $430 in the prior-year period — up 41159591.9% year over year. Investors often review this figure alongside Arbor Rapha Capital Bioholdings I's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARCK's common stock moved from $430 to $180M — a 41159591.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Arbor Rapha Capital Bioholdings I's operating scale or balance-sheet position.

A common stock figure of $180M for ARCK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ARCK's common stock ($180M), review year-over-year change from $430, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.